City

Fort Worth (1)

Naples (1)

Condition

GHD (3)

Obesity (1)

Overall Status

Not yet recruiting (2)

Completed (1)

Sign in for free

Phase

phase 3 (3)

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd. (1)

Changchun GeneScience Pharmaceuticals Co., Ltd. (1)

Federico II University (1)

Collaborator

Intervention

genotropin (1)

gensci004 (1)

peg-somatropin (1)

recombinant gh saizen (merck-serono) (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

ghd

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

GHD Trial (PEG-somatropin)

Not yet recruiting

GHD

PEG-somatropin

(no location specified)

Sep 7, 2023

GHD Trial in Fort Worth (GenSci004, Genotropin)

Not yet recruiting

GHD

Fort Worth, Texas

Cook Childrens

Aug 24, 2023

Obesity, GHD Trial in Naples (Recombinant GH Saizen (Merck-Serono))

Completed

Obesity
GHD

Recombinant GH Saizen (Merck-Serono)

Naples, Italy

Department of Molecular and Clinical Endocrinology and Oncology

Mar 27, 2008